Kevin R Flaherty

Kevin R Flaherty

UNVERIFIED PROFILE

Are you Kevin R Flaherty?   Register this Author

Register author
Kevin R Flaherty

Kevin R Flaherty

Publications by authors named "Kevin R Flaherty"

Are you Kevin R Flaherty?   Register this Author

100Publications

3398Reads

19Profile Views

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. Reply.

N Engl J Med 2020 02;382(8):781

National Jewish Health, Denver, CO

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1917224DOI Listing
February 2020

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.

N Engl J Med 2019 10 29;381(18):1718-1727. Epub 2019 Sep 29.

From the Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor (K.R.F.); the National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust (A.U.W.), the National Heart and Lung Institute, Imperial College (A.U.W., A.D., S.L.F.W.), and the Department of Radiology, Royal Brompton and Harefield NHS Foundation Trust (A.D.) - all in London; the National Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Claude Bernard University Lyon 1, Unité Mixte de Recherche 754, Lyon, France (V.C.); the Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai City, Japan (Y.I.); Fondazione Policlinico A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome (L.R.); McMaster University and St. Joseph's Healthcare, Hamilton, ON, Canada (M.K.); Boehringer Ingelheim International, Ingelheim am Rhein (K.T., S.S., E.C.-B., M.Q., T.H.), the Department of Sports Medicine, University of Tübingen, Tübingen (K.T.), and Boehringer Ingelheim Pharma, Biberach (B.R., R.-G.G.) - all in Germany; Boehringer Ingelheim, Brussels (C.C.); Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT (R.S.-H.); and the Department of Medicine, National Jewish Health, Denver (K.K.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1908681DOI Listing
October 2019

The characterisation of interstitial lung disease multidisciplinary team meetings: a global study.

ERJ Open Res 2019 Apr 1;5(2). Epub 2019 Apr 1.

Division of Pulmonary and Critical Care Medicine, Dept of Medicine, University of Michigan, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/23120541.00209-2018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441673PMC
April 2019

Frailty and geriatric conditions in older patients with idiopathic pulmonary fibrosis.

Respir Med 2019 03 24;148:6-12. Epub 2019 Jan 24.

Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Michigan Health System, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmed.2019.01.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690058PMC
March 2019

Pulmonary fibrosis: "idiopathic" is not "cryptogenic".

Eur Respir J 2019 Mar 18;53(3). Epub 2019 Mar 18.

Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.00400-2019DOI Listing
March 2019

Idiopathic interstitial pneumonia or idiopathic interstitial pneumonitis: what's in a name?

Eur Respir J 2019 Feb 14;53(2). Epub 2019 Feb 14.

Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.01939-2018DOI Listing
February 2019

Lung function outcomes in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis.

Respir Med 2019 01 19;146:42-48. Epub 2018 Nov 19.

National Institute for Health Research Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust, and National Heart and Lung Institute, Imperial College London, UK. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09546111183037
Publisher Site
http://dx.doi.org/10.1016/j.rmed.2018.11.012DOI Listing
January 2019

Stability or improvement in forced vital capacity with nintedanib in patients with idiopathic pulmonary fibrosis.

Eur Respir J 2018 08 2;52(2). Epub 2018 Aug 2.

Università Cattolica del Sacro Cuore, Fondazione Policlinico A. Gemelli, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.02593-2017DOI Listing
August 2018

What's in a name? That which we call IPF, by any other name would act the same.

Eur Respir J 2018 05 17;51(5). Epub 2018 May 17.

Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.00692-2018DOI Listing
May 2018

A Phase 2 Randomized Controlled Study of Tralokinumab in Subjects with Idiopathic Pulmonary Fibrosis.

Am J Respir Crit Care Med 2018 01;197(1):94-103

10 Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1164/rccm.201704-0784OCDOI Listing
January 2018

Idiopathic Pulmonary Fibrosis: Data-driven Textural Analysis of Extent of Fibrosis at Baseline and 15-Month Follow-up.

Radiology 2017 10 10;285(1):270-278. Epub 2017 May 10.

From the Department of Radiology (S.M.H., D.A.L.) and Division of Biostatistics and Bioinformatics (M.S.), National Jewish Health, 1440 Jackson St, Denver, CO 80206-2761; Department of Radiology, St. Marianna University School of Medicine, Kawasaki, Japan (K.Y.); Department of Radiology, Kaiser Permanente, Denver, Colo (J.H.); Department of Radiology, Keimyung University School of Medicine, Daegu, Republic of Korea (B.H.R.); Department of Radiology and Imaging Sciences, University of Utah, Salt Lake City, Utah (J.D.S.); Division of Pulmonary Sciences & Critical Care Medicine, University of Colorado, Aurora, Colo (M.I.S.); Departments of Pulmonology (K.R.F.) and Radiology (E.A.K.), University of Michigan, Ann Arbor, Mich; and Clinical Research Imaging Centre, University of Edinburgh, Edinburgh, Scotland (E.J.R.v.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2017161177DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621716PMC
October 2017

Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPF.

PLoS One 2016 4;11(8):e0159878. Epub 2016 Aug 4.

Pulmonary and Critical Care Medicine Division, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0159878PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973878PMC
August 2017

Comprehensive and Individualized Patient Care in Idiopathic Pulmonary Fibrosis: Refining Approaches to Diagnosis, Prognosis, and Treatment.

Chest 2017 05;151(5):1173-1174

Division of Pulmonary and Critical Care Medicine, and Idiopathic Pulmonary Fibrosis Foundation Clinical Care Site, University of Michigan, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chest.2017.03.017DOI Listing
May 2017

Effect of Nintedanib in Subgroups of Idiopathic Pulmonary Fibrosis by Diagnostic Criteria.

Am J Respir Crit Care Med 2017 01;195(1):78-85

2 Royal Brompton and Harefield NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1164/rccm.201602-0402OCDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214917PMC
January 2017

The diagnosis of idiopathic pulmonary fibrosis: current and future approaches.

Lancet Respir Med 2017 01 6;5(1):61-71. Epub 2016 Dec 6.

Catholic University of the Sacred Heart, A. Gemelli University Hospital, Rome, Italy; Academic Unit of Clinical and Experimental Sciences, NIHR Southampton Respiratory Biomedical Research Unit, University Hospital Southampton, Southampton, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(16)30325-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524148PMC
January 2017

Clinical characteristics in patients with asymmetric idiopathic pulmonary fibrosis.

Respir Med 2016 10 31;119:96-101. Epub 2016 Aug 31.

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Health System, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074687PMC
http://dx.doi.org/10.1016/j.rmed.2016.08.028DOI Listing
October 2016

Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: A cross sectional analysis in ILD patients undergoing lung tissue sampling.

Respir Med 2016 09 28;118:88-95. Epub 2016 Jul 28.

Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Michigan, 1500 E Medical Center Drive 3916, Taubman Center, Ann Arbor, MI, 48109, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmed.2016.07.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008035PMC
September 2016

Clinical Trial Design Based on Time to Death/Progression.

Am J Respir Crit Care Med 2016 09;194(6):653-4

2 Division of Pulmonary and Critical Care Medicine University of Michigan Health System Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1164/rccm.201604-0819EDDOI Listing
September 2016

Idiopathic Pulmonary Fibrosis: Gender-Age-Physiology Index Stage for Predicting Future Lung Function Decline.

Chest 2016 Feb 12;149(2):491-498. Epub 2016 Jan 12.

Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Michigan, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1378/chest.15-0530DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944785PMC
February 2016

Idiopathic non-specific interstitial pneumonia.

Respirology 2016 Feb 13;21(2):259-68. Epub 2015 Nov 13.

Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, Michigan, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/resp.12674DOI Listing
February 2016

Update in Interstitial Lung Disease 2014.

Am J Respir Crit Care Med 2015 Sep;192(5):538-43

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1164/rccm.201504-0768upDOI Listing
September 2015

Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials.

Lancet Respir Med 2015 May 15;3(5):388-96. Epub 2015 Apr 15.

Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Michigan, Ann Arbor, MI, USA; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Weill Cornell Medical College, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(15)00093-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760351PMC
May 2015

Inflammatory leukocyte phenotypes correlate with disease progression in idiopathic pulmonary fibrosis.

Front Med 2014 Dec;1(56)

Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fmed.2014.00056DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286285PMC
December 2014

Open-access biorepository for idiopathic pulmonary fibrosis. The way forward.

Ann Am Thorac Soc 2014 Oct;11(8):1171-5

1 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1513/AnnalsATS.201406-289OIDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299004PMC
October 2014

Smoking-related idiopathic interstitial pneumonia.

Eur Respir J 2014 Sep 25;44(3):594-602. Epub 2014 Jul 25.

Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA Dept of Medicine, Division of Pulmonary and Critical Care Medicine, Weill Cornell Medical Center, New York, NY, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/09031936.00166813DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366053PMC
September 2014

Idiopathic or connective tissue disease-associated interstitial lung disease: a case of HRCT mimicry.

Thorax 2014 Mar 6;69(3):205-6. Epub 2014 Jan 6.

Division of Pulmonary/Critical Care Medicine, Department of Internal Medicine, University of Michigan, , Ann Arbor, Michigan, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/thoraxjnl-2013-204864DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655432PMC
March 2014

Pathogenesis, current treatments and future directions for idiopathic pulmonary fibrosis.

Curr Opin Pharmacol 2013 Jun 18;13(3):377-85. Epub 2013 Apr 18.

Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI 48109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.coph.2013.03.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686907PMC
June 2013

Preoperative pulmonary artery pressure and mortality after lung transplantation.

Asian Cardiovasc Thorac Ann 2013 Jun;21(3):326-30

Departments of Surgery and Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0218492312459972DOI Listing
June 2013

Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials.

Am J Respir Crit Care Med 2012 May 13;185(10):1044-8. Epub 2012 Apr 13.

Division of Pulmonary and Critical Care Medicine, Campus Box 356175, University of Washington, Seattle, WA 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1164/rccm.201201-0006PPDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448580PMC
May 2012

Clinical year in review I: interstitial lung disease, occupational and environmental lung disease, education of residents and fellows, and pediatrics.

Proc Am Thorac Soc 2011 Sep;8(5):389-97

Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, Michigan, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1513/pats.201108-045TTDOI Listing
September 2011

Clinical year in review II: lung cancer, sleep apnea, interventional pulmonary/pleural disease, cystic fibrosis.

Proc Am Thorac Soc 2011 Sep;8(5):398-403

Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1513/pats.201108-044TTDOI Listing
September 2011

Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.

N Engl J Med 2011 Sep;365(12):1079-87

Center for Rare Lung Diseases, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1103690DOI Listing
September 2011

A polyurethane cuffed endotracheal tube is associated with decreased rates of ventilator-associated pneumonia.

J Crit Care 2011 Jun 23;26(3):280-6. Epub 2010 Jul 23.

Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcrc.2010.05.035DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009728PMC
June 2011

Clinical year in review I: interstitial lung disease, pulmonary vascular disease and venous thromboembolism, diagnostic imaging, and lung cancer.

Proc Am Thorac Soc 2010 Sep;7(5):297-304

Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1513/pats.201007-053TTDOI Listing
September 2010

Clinical year in review III: pulmonary rehabilitation, respiratory health effects of smoking, genetics of lung disease, and chronic obstructive pulmonary disease.

Proc Am Thorac Soc 2010 Sep;7(5):312-7

Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Aurora, Colorado, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1513/pats.201006-043TTDOI Listing
September 2010

Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis.

Am J Respir Crit Care Med 2010 Apr 7;181(8):832-7. Epub 2010 Jan 7.

Division of Respiratory Medicine, University of Calgary, Calgary, AB, T1Y 6J4 Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1164/rccm.200906-0959OCDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2854332PMC
April 2010

Diagnosing fibrotic lung disease: when is high-resolution computed tomography sufficient to make a diagnosis of idiopathic pulmonary fibrosis?

Respirology 2009 Sep;14(7):934-9

Departments of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1440-1843.2009.01626.xDOI Listing
September 2009

Clinical year in review II: Sepsis, mechanical ventilation, occupational and environmental lung disease, and sleep.

Proc Am Thorac Soc 2009 Sep;6(6):494-9

Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1513/pats.200907-060TTDOI Listing
September 2009

Clinical year in review IV: Pediatric pulmonary and critical care, cystic fibrosis, asthma, and pleural disease.

Authors:
Kevin R Flaherty

Proc Am Thorac Soc 2009 Sep;6(6):506-11

Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, 3916 Taubman Center, Ann Arbor, MI 48109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1513/pats.200907-066TTDOI Listing
September 2009

Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis.

Am J Respir Crit Care Med 2009 Apr 29;179(8):717-23. Epub 2009 Jan 29.

Department of Pneumology, University Freiburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1164/rccm.200808-1201OCDOI Listing
April 2009